Nissho Corporation

Matsushita Electronics Corporation

Nipro Corporation

Topy Kogyo Kabushiki Kaisha

Yukio Nakamura

Yasuhiro Tsutsui

Makoto Sato

Kentaro Oba

Masahiro Kawasaki

Masao Nakayama

Toshio Fujiwara

Isamu Yuasa

Noboru Yoshida

Takeo Kikuchi

Yoshio Fukui

Katsuji Tara

Etsuro Sugisaki

Shiho Yamaguchi

Kenichi Iwamitsu

An albumin preparation that prevents onset of hepatic encephalopathy caused by conventional amino acid preparations and enhances an effect of improving the symptoms is provided. The albumin preparation containing amino acids is characterized in that a content of albumin is 0.01 to 1.0 w/v %, a content of plurality of amino acids containing branched amino acid is 5 to 10 w/v %, a content of the branched amino acids is equal to or more than 30 w/w % on the basis of the content of total amino acids and further, the Fischer ratio (branched amino acid/[phenylalanine+tyrosine] (molar ratio)) is equal to or more than 20.

Amino acid-containing albumin preparation

A peritoneal dialysis fluid characterized by the addition of 0.1 to 30 g/L of albumin. The peritoneal dialysis fluid reduces the occurrence of peritonitis during peritoneal dialysis.

Peritoneal dialysis fluid

Semiconductor device

A pharmaceutical composition for treating inflammatory diseases, comprising (A) an effective amount of hyaluronic acid or its salt, and (B) an effective amount of an anti-inflammatory agent. The composition exhibits a synergistic therapeutic effect on inflammations and is useful for treating inflammatory diseases, particularly diseases of joint with inflammation.

Combined anti-inflammatory agent

Growing community of inventors

Osaka, Japan

Yukio Nakamura